Seattle Genetics (SGEN) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Income (loss) from operations: -32.41M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Income (loss) from operations: -32.41M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $95.4 million versus the consensus estimate of $94.14 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'
- First Watch (FWRG) PT Lowered to $15 at DA Davidson, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
